secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK:        0001062822
Form:       8-K
Filed at:   2023-04-27T23:59:59+00:00
Accession:  0001062822-23-000015
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexicon shareholders approve amendment to increase equity plan shares to 55M
----------------------------------------------------------------------------

- Stockholders approved amendment to 2017 Equity Incentive Plan, increasing authorized shares from 30,000,000 to 55,000,000.
- Amendment to 2017 Non-Employee Directors' Equity Incentive Plan increased share reserve from 1,200,000 to 2,000,000.
- Voting results: For: 110,232,367; Against: 24,746,403; Abstain: 16,261,356; Broker non-votes: 13,664,122.
- Amendments adopted by Board on Feb 9, 2023 and approved at annual meeting on April 27, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1062822/000106282223000015/0001062822-23-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1062822/000106282223000015/lxrx-20230427.htm
  HTML page:      https://secwatch.observer/filing/0001062822-23-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer